45 CFR § 180 compliance
D · 65
This hospital published part of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
○Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
9,334
Insurances with rates
6
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 3217864 | OCREVUS (OCRELIZUMAB) SDPF:300 MG/10 ML | $93,951 | $75,161 | — | — | 4 |
| 19187893 | CHROMOSOMAL MICROARRAY ANALYSIS 45685 | $78,831 | $63,065 | — | — | 4 |
| 3215796 | KEYTRUDA (PEMBROLIZUMAB) 100MG/4ML-2 PK | $52,050 | $41,640 | — | — | 4 |
| 3213110 | TECENTRIQ (ATEZOLIZUMAB) INJ:1200 MG | $50,272 | $40,218 | — | — | 4 |
| 3213911 | LUPRON DEPOT KT 45 MG | $49,312 | $39,449 | — | — | 4 |
| 3217418 | DARZALEX FASPRO 1800 MG SDPF | $45,401 | $36,321 | — | — | 4 |
| 3200022 | ACTIVASE (ALTEPLASE):100 MG | $44,658 | $35,726 | — | — | 4 |
| 3212471 | OPDIVO (NIVOLUMAB) SDPF:240 MG | $37,347 | $29,878 | — | — | 4 |
| 3217341 | CYRAMZA (RAMUCIRUMAB) SDPF:500 MG/50ML | $35,713 | $28,571 | — | — | 4 |
| 3214390 | ENTYVIO (VEDOLIZUMAB): 300 MG | $35,145 | $28,116 | — | — | 4 |
| 3299998 | Rituxan HYCELA INJ 1400 MG/11.7 ML | $33,896 | $27,117 | — | — | 4 |
| 3207705 | TYSABRI (NATALIZUMAB): 300 MG/15 ML INJ | $32,331 | $25,865 | — | — | 4 |
| 3207400 | NEULASTA (PEGFILGRASTIM) INJ:6 MG | $26,651 | $21,321 | — | — | 4 |
| 3213909 | NEULASTA ONPRO KT (PEGFILGRASTIM) 6MG | $26,651 | $21,321 | — | — | 4 |
| 3213998 | KEYTRUDA (PEMBROLIZUMAB) SDPF:100MG/4ML | $26,025 | $20,820 | — | — | 4 |
| 3209084 | LUPRON DEPOT 22.5MG | $25,653 | $20,523 | — | — | 4 |
| 3210713 | HERCEPTIN (TRASTUZUMAB):440MG | $21,886 | $17,509 | — | — | 4 |
| 3207681 | ALIMTA (PEMETREXED):500 MG | $20,779 | $16,623 | — | — | 4 |
| 3209657 | PRIVIGEN (IVIG) 10%:40 GM/400 ML | $19,188 | $15,351 | — | — | 4 |
| 3216267 | IMFINZI (DURVALUMAB) INJ:500 MG/10ML | $19,173 | $15,338 | — | — | 4 |
| 3207512 | RITUXAN (RITUXIMAB):500 MG | $19,123 | $15,298 | — | — | 4 |
| 3214051 | RABIES IMMUNE GLOBULIN:300 UNITS/ML-5 ML | $17,879 | $14,303 | — | — | 4 |
| 1700431 | INSERT/REPLACE TEMP TRANSVENOUS PACEMAKR | $17,336 | $13,869 | — | — | 0 |
| 3215742 | UDENYCA (PEGFILGRASTIM-CBQV) INJ:6 MG | $17,001 | $13,601 | — | — | 4 |
| 3209374 | AVASTIN (BEVACIZUMAB) SDPF:400 MG/16 ML | $16,923 | $13,538 | — | — | 4 |
| 1401492 | KYPHOPACK TRAY FIRST FRACTURE KPT 2005 | $16,514 | $13,212 | — | — | 0 |
| 1401493 | KYPHOPAK TRAY FIRST FRACTURE KPT1505 | $16,514 | $13,212 | — | — | 0 |
| 3207256 | TNKASE (TENECTEPLASE) INJ:50 MG | $16,358 | $13,086 | — | — | 4 |
| 3216008 | TRUXIMA SF (RITUXIMAB-ABBS):500 MG/50 ML | $15,837 | $12,669 | — | — | 4 |
| 3210030 | XGEVA (DENOSUMAB) INJ:120 MG/1.7 ML | $14,638 | $11,710 | — | — | 4 |
| 1700435 | REPAIR BLOOD VESSEL HAND, FINGER | $14,272 | $11,417 | — | — | 0 |
| 1901084 | BRCA1 AND BRCA2 COMPREHENSIVE 485030 | $13,506 | $10,805 | — | — | 4 |
| 3217816 | ENHERTU (FAM-TRAZTUZUMAB-DER-NXKI):100MG | $13,255 | $10,604 | — | — | 4 |
| 3217215 | HEMO-7 HEMOSPRAY ENDOSCOPIC | $12,510 | $10,008 | — | — | 0 |
| 3217216 | HEMO-10 HEMOSPRAY ENDOSCOPIC | $12,510 | $10,008 | — | — | 0 |
| 3217739 | EVENITY INJ:210 MG (2X105MG/1.17ML SYRG) | $11,602 | $9,281 | — | — | 4 |
| 3212667 | KYPROLIS (CARFILZOMIB) INJ:60 MG | $11,426 | $9,141 | — | — | 4 |
| 1404654 | LCP PROXIMAL HUMERUS PLATE | $11,207 | $8,965 | — | — | 0 |
| 3216111 | NPLATE (ROMIPLOSTIM) INJ:250 MCG | $10,961 | $8,769 | — | — | 4 |
| 1404653 | LCP PROXIMAL HUMERUS PLATE | $10,866 | $8,692 | — | — | 0 |
| 3211187 | BENDEKA (BENDAMUSTINE) INJ:100 MG/4 ML | $10,826 | $8,660 | — | — | 4 |
| 3207253 | PARAPLATIN (CARBOPLATIN) IV SOLN:450 MG | $10,627 | $8,502 | — | — | 4 |
| 1910127 | BRCA 1 AND 2 SEQUENCING AND DELETION/DUP | $10,478 | $8,383 | — | — | 4 |
| 3209849 | TREANDA 100MG/VIAL | $10,469 | $8,376 | — | — | 4 |
| 1404784 | ARTHREX SPEED BRIDGE KIT | $10,290 | $8,232 | — | — | 0 |
| 3217642 | HERZUMA (TRASTUZUMAB-PKRB) INJ:420 MG | $10,206 | $8,165 | — | — | 4 |
| 1700433 | REPAIR BLOOD VESSEL UPPER EXTREMITY | $9,894 | $7,915 | — | — | 0 |
| 3217756 | BENLYSTA (BELIMUMAB) INJ:400 MG | $9,833 | $7,866 | — | — | 4 |
| 3217154 | STELARA (USTEKINUMAB) SDPF:130 MG/26 ML | $9,648 | $7,718 | — | — | 4 |
| 3209114 | PRIVIGEN (IVIG) 10%:20 GM/200 ML | $9,594 | $7,675 | — | — | 4 |
Showing top 50 of 9,334 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.